United States · FDA National Drug Code directory
BRIVARACETAM
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 59651-995_bd0525ad-75ee-4870-8e88-db05b3aae880
- Product NDC
- 59651-995
- Form
- SOLUTION
- Composition / generic term
- BRIVARACETAM
- Labeler
- Aurobindo Pharma Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20260810
- Source listing expiry
- 20271231
Source-listed ingredients
- BRIVARACETAM — 10 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 300 mL in 1 BOTTLE, PLASTIC (59651-995-03) · 59651-995-03
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →